Zimmer Biomet Showcases Robotic and AI Innovations at AAOS 2026

Event summary

  • Zimmer Biomet will unveil new clinical and operational data at the AAOS 2026 Annual Meeting on March 5, 2026.
  • The company's Chief Movement Officer, Arnold Schwarzenegger, will be the Presidential Guest Speaker.
  • Zimmer Biomet will showcase its 'Magnificent Seven' technologies, including ROSA® Knee with OptimiZe™ and TMINI® Miniature Robotic System.
  • New data will highlight safety and efficacy of the Oxford® Cementless Partial Knee and efficiency improvements in ambulatory surgery centers (ASCs).
  • The company will also feature innovations from its recent Paragon 28 acquisition.

The big picture

Zimmer Biomet's presence at the AAOS 2026 Annual Meeting underscores its strategic focus on integrating robotic and digital technologies with orthopedic implants. The company aims to transform patient outcomes through data-driven insights and innovative solutions. With a comprehensive portfolio and a progressive culture of evolution, Zimmer Biomet is positioned to deliver high-quality solutions to patients and providers globally.

What we're watching

Innovation Leadership
Whether Zimmer Biomet can maintain its leadership position in orthopedic robotics and AI-driven navigation technologies.
Clinical Data Impact
How the new clinical data on smart implants and digital care platforms will influence market adoption.
Integration Success
The pace at which Zimmer Biomet can integrate and leverage innovations from the Paragon 28 acquisition.

Related topics

Product Launch